Biomark Diagnostics (XCNQ:BUX) Other Long Term Assets : C$0.03 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Other Long Term Assets?

Biomark Diagnostics's other long-term assets for the quarter that ended in Dec. 2024 was C$0.03 Mil.

Biomark Diagnostics's quarterly other long-term assets increased from Jun. 2024 (C$0.03 Mil) to Sep. 2024 (C$0.04 Mil) but then stayed the same from Sep. 2024 (C$0.04 Mil) to Dec. 2024 (C$0.03 Mil).

Biomark Diagnostics's annual other long-term assets increased from Mar. 2022 (C$0.00 Mil) to Mar. 2023 (C$0.01 Mil) and increased from Mar. 2023 (C$0.01 Mil) to Mar. 2024 (C$0.03 Mil).

Biomark Diagnostics Other Long Term Assets Historical Data

The historical data trend for Biomark Diagnostics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Other Long Term Assets Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long Term Assets

Get a 7-Day Free Trial

0.01

0.03

Biomark Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															0.02	0.03	0.03	0.04	0.03

Biomark Diagnostics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

BMKDF:USA 20B:Germany

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Executives

Rashid Ahmed Maula Bux	Director
Guoyu Huang	Senior Officer

Biomark Diagnostics Headlines

No Headlines